The Venture Equity Fund invests in early-stage technologies poised to capitalize on the paradigm shifts in healthcare. The coming decade will bring burgeoning opportunities as entrepreneurs strive to reduce costs and improve the quality of care and services. Adaptive Health Capital offers Portfolio Companies “smart money”: investment accompanied by active oversight, dedicating mentoring, and unmatched access to a big network of healthcare leadership from all walks of industry.
The Venture Equity Fund capitalizes on hundreds of “first look” investment opportunities that Adaptive Heath Capital’s founders receive in early-stage healthcare companies, focusing on the niche between the angel investment “seed” stage and venture capital “Series A” investment stage. Often referred to as a “Valley of Death” where healthcare entrepreneurs have become revenue-positive but struggle and founder before becoming cash flow-positive, Adaptive Health Capital sees a unique chance to support promising investment-worthy opportunities beyond seed and before exit. In doing do, the Fund seeks to infuse genuine value as active investors. The focus is on business-to-business companies that recognize and are positioned to seize upon paradigm shifts in healthcare, including the “outpatient-ification” of healthcare services and the shift from volume-based to value-based models. The Venture Equity Fund focuses on companies in four principal verticals:
- Aging in Place technologies
- Digital Health
- Care Coordination
Adaptive Health Capital seeks companies in these verticals that are well-positioned to take maximal advantage of dramatic improvements in the precision of care delivery services through biomedical research, healthcare information technology, and informatics. While other funds hunt for the “home run” on the rare “unicorn,” the Venture Equity Fund seeks to take advantage of “singles” and “doubles,” i.e. more modest but nonetheless profitable healthcare investment opportunities.